Unravelling Salmonella Pathogenesis: Effector-Mediated Post-Translational Modifications, Alternative Therapies, and Advances in Rapid Detection
ACS Infectious Diseases · 2026
DOI: 10.1021/acsinfecdis.5c00418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, 2026. Verfasst von Umesh Chopra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, Karnataka, India. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Salmonella, Salmonella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 203 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India, Indian Institute of Science, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Salmonella infections remain a priority concern in both developed and developing regions due to antimicrobial resistance and the lack of proper diagnosis. While substantial progress has been made in deciphering the pathogenesis of this ancient pathogen, emerging insights into host–pathogen interactions, particularly those mediated by post-translational modifications (PTMs) orchestrated by bacterial effectors, offer promising avenues for identifying novel drug targets and advancing host-directed therapies. The rise in antimicrobial resistance among priority Salmonella serovars, particularly in the food industry, underscores the urgent need for effective alternatives to antibiotic therapy alongside rapid and accurate diagnostic tools for identifying drug-resistant strains. In this context, phage therapy, along with probiotics, prebiotics, small molecule inhibitors, optimized antimicrobial peptides, and host-directed therapies, has gained attention as a potential therapeutic approach. Simultaneously, diagnosis tools incorporating modern techniques such as high-throughput gene analysis, multiplex ELISAs, microfluidic devices with nanotechnology, computer modeling, and MALDI-TOF pave the way for improved accuracy, high sensitivity, and affordable solutions to a rising concern of misdiagnosis and dependency on culture-based techniques. This review aims to highlight recent discoveries in post-translational modifications by Salmonella effectors affecting host protein localization and function. We also discuss current progress in alternative therapeutic strategies and next-generation diagnostics aimed at combating drug-resistant Salmonella infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, Karnataka, India.
- School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, Kerala, India.
ORCID-Profile: Dipshikha Chakravortty
Förderung
- Department of Atomic Energy, Government of India
- Indian Institute of Science
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Chopra, U., Sabu, M. K., Prakash, C., & Chakravortty, D. (2026). Unravelling Salmonella Pathogenesis: Effector-Mediated Post-Translational Modifications, Alternative Therapies, and Advances in Rapid Detection. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00418
Vancouver
Chopra U, Sabu MK, Prakash C, Chakravortty D. Unravelling Salmonella Pathogenesis: Effector-Mediated Post-Translational Modifications, Alternative Therapies, and Advances in Rapid Detection. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.5c00418
BibTeX
@article{Chopra2026,
author = {Chopra, Umesh and Sabu, Maria Kondooparambil and Prakash, Chandhana and Chakravortty, Dipshikha},
title = {Unravelling Salmonella Pathogenesis: Effector-Mediated Post-Translational Modifications, Alternative Therapies, and Advances in Rapid Detection},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.5c00418}
}
EUVIMED